Home
June 2008 July 2008 August 2008
Su Mo Tu We Th Fr Sa
Week 27 1 2 3 4 5
Week 28 6 7 8 9 10 11 12
Week 29 13 14 15 16 17 18 19
Week 30 20 21 22 23 24 25 26
Week 31 27 28 29 30 31

Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Outcomes of a Prospective, Worldwide Clinical Study Show Comments PDF Print E-mail
  
Thursday, 17 January 2008

BERKELEY, CA (UroToday.com) - The results of one of the earliest and largest prospective, multicenter clinical trials of sacral neuromodulation (SNM) therapy was recently reported after the conclusion of the trial with 5 year follow-up data. Van Kerrebroeck and colleagues from throughout Europe and North America evaluated the long-term safety and efficacy of sacral neuromodulation in 3 groups of patients. Ninety-six patients were treated for urge-incontinence, 25 with urgency frequency, and 31 with urinary retention. Eighty-seven per cent of the 163 patients were female and 152 underwent InterstimR implantation following test stimulation. The overall 5 year results show a moderately effective treatment but in the vast majority of cases, not a “cure-all” for voiding dysfunction. For patients with urge incontinence, mean leaking episodes per day decreased from 9.6 + 6.0 to 3.9 + 4.0 at 5 years. Urgency frequency patients noted decreases in voids per day from 19.3 + 7.0 to 14.8 + 7.6 at 5 years with increases in voided volumes of about 70cc on average. Those in retention were able to cut back on intermittent catheterization frequency from 5 times daily to twice daily. At five years only 16 devices were explanted because of complications or lack of efficacy. Of the 152 patients implanted, 39.5% had an adverse event requiring surgical intervention. The study shows a high correlation between 1 and 5 year success rates for treated patients. There is still room for improving outcomes and hopefully a less expensive, more efficacious device can be developed using this expanding technology. For the time being it appears that SNM is a useful, safe long-term therapy for properly selected patients with realistic expectations. van Kerrebroeck PEV, van Voskuilen AC, Heesakkers JPFA, á Nijholt AABL, Siegel S, Jonas U, Fowler CJ, Fall M, Gajewski JB, Hassouna MM, Cappellano F, Elhilali MM, Milam DF, Das AF, Dijkema HE, van den Hombergh U

J of Urol. 178(5):2029-2034, November 2007
doi:10.1016/j.juro.2007.07.032

PubMed Abstract
PMID: 17869298

UroToday.com Painful Bladder Syndrome Section

Written by Christopher P. Evans, MD, a Contributing Editor with UroToday.

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 2
PoorBest


 
Visitor Ratings:
Healthcare Professionals:
4 (2 votes)